IN2012DN00411A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00411A
IN2012DN00411A IN411DEN2012A IN2012DN00411A IN 2012DN00411 A IN2012DN00411 A IN 2012DN00411A IN 411DEN2012 A IN411DEN2012 A IN 411DEN2012A IN 2012DN00411 A IN2012DN00411 A IN 2012DN00411A
Authority
IN
India
Prior art keywords
morpholinone
nitrating
nitrophenyl
phenyl
preparing
Prior art date
Application number
Other languages
English (en)
Inventor
Thomas Christian
Berwe Mathias
Straub Alexander
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of IN2012DN00411A publication Critical patent/IN2012DN00411A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN411DEN2012 2003-09-15 2004-09-09 IN2012DN00411A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10342570A DE10342570A1 (de) 2003-09-15 2003-09-15 Verfahren zur Herstellung von 4-(4-Aminophenyl)-3-morpholinon
PCT/EP2004/010054 WO2005026135A1 (fr) 2003-09-15 2004-09-09 Procede de production de 4-(4-aminophenyl)-3-morpholinone

Publications (1)

Publication Number Publication Date
IN2012DN00411A true IN2012DN00411A (fr) 2015-08-21

Family

ID=34305779

Family Applications (1)

Application Number Title Priority Date Filing Date
IN411DEN2012 IN2012DN00411A (fr) 2003-09-15 2004-09-09

Country Status (23)

Country Link
US (1) US7598378B2 (fr)
EP (1) EP1664004B1 (fr)
JP (1) JP4852419B2 (fr)
KR (1) KR101148264B1 (fr)
CN (1) CN100430384C (fr)
AU (1) AU2004272255B2 (fr)
BR (1) BRPI0414382B1 (fr)
CA (1) CA2538906C (fr)
CY (1) CY1116644T1 (fr)
DE (1) DE10342570A1 (fr)
DK (1) DK1664004T3 (fr)
EG (1) EG26605A (fr)
ES (1) ES2545072T3 (fr)
HK (1) HK1098134A1 (fr)
HU (1) HUE025273T2 (fr)
IL (1) IL174194A (fr)
IN (1) IN2012DN00411A (fr)
MX (1) MXPA06002883A (fr)
PL (1) PL1664004T3 (fr)
PT (1) PT1664004E (fr)
SI (1) SI1664004T1 (fr)
WO (1) WO2005026135A1 (fr)
ZA (1) ZA200602093B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100898361B1 (ko) 2008-07-03 2009-05-20 주식회사 레고켐 바이오사이언스 P4 위치에 사이클릭 아미독심 또는 사이클릭 아미드라존기를 가지는 FXa 저해제, 이의 유도체, 제조방법 및이를 함유하는 의약 조성물
US7816355B1 (en) * 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof
WO2011080341A1 (fr) 2010-01-04 2011-07-07 Enantia, S.L. Procédé de préparation de rivaroxaban et ses intermédiaires
DE102010018299A1 (de) * 2010-04-23 2011-10-27 Archimica Gmbh Verfahren zur Herstellung von 4-(4-Aminophenyl)-morpholin-3-on
EP2613787A4 (fr) * 2010-09-07 2014-04-16 Symed Labs Ltd Procédés de préparation de 4-{4-[5(s)-(aminométhyl)-2-oxo-1,3-oxazolidin-3-yl]phényl} morpholin-3-one
CA2815063C (fr) 2010-10-18 2016-11-22 Apotex Pharmachem Inc. Procedes de preparation de rivaroxaban et ses intermediaires
WO2012140061A1 (fr) 2011-04-11 2012-10-18 Sandoz Ag Procédé de préparation d'oxazolidinones substituées
US9556163B2 (en) 2011-05-06 2017-01-31 Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag Process for the preparation of a rivaroxaban and intermediates formed in said process
WO2012156983A1 (fr) * 2011-05-16 2012-11-22 Symed Labs Limited Procédés pour la préparation de 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phényl]-1,3-oxazolidin-5-yl}méthyl)-2-thiophènecarboxamide
CN102320988B (zh) * 2011-06-03 2014-04-09 中国科学院上海有机化学研究所 4-(4-氨基苯基)-3-吗啉酮中间体酰胺、合成方法和用途
CN103288814B (zh) * 2012-02-24 2016-07-06 国药集团国瑞药业有限公司 一种利伐沙班中间体的制备方法
CN102746288B (zh) * 2012-07-24 2015-04-08 常州制药厂有限公司 一种抗凝血药及其关键中间体的制备方法
US9663505B2 (en) 2013-03-25 2017-05-30 Glenmark Pharmaceuticals Limited Process for the preparation of rivaroxaban
KR20140127651A (ko) * 2013-04-25 2014-11-04 주식회사 종근당 4-(4-아미노페닐)-3-모폴리논의 신규한 제조 방법
CN103232446B (zh) * 2013-05-17 2015-09-23 天津药物研究院 一种噁唑烷酮衍生物晶型ⅱ及其制备方法和用途
WO2015067630A1 (fr) 2013-11-08 2015-05-14 Bayer Pharma Aktiengesellschaft Uraciles substitués et leur utilisation
CN103709116B (zh) * 2013-12-10 2015-09-23 四川大学 一种4-(4-烷氧羰氨基)苯基-3-吗啉酮的制备方法
CN103755657B (zh) * 2013-12-25 2015-10-14 湖南方盛制药股份有限公司 一种利伐沙班中间体的制备方法
CN104974059B (zh) * 2014-04-14 2016-11-16 北大方正集团有限公司 一种利伐沙班中间体及其制备方法
CN105085370B (zh) * 2014-04-22 2017-04-12 北大方正集团有限公司 (s)‑1‑卤代‑2‑[2‑(1,3‑二氧异吲哚)基]乙基氯甲酸酯及其制备方法
WO2016030669A1 (fr) 2014-08-25 2016-03-03 Cipla Limited Procédé de préparation du rivaroxaban
CN104478820B (zh) * 2014-12-22 2016-08-31 杭州瀚康生物医药科技有限公司 一种利伐沙班中间体的制备方法
CN104817548B (zh) * 2015-03-19 2017-12-01 郑州轻工业学院 一种对氢氧化锂、氢氧化钠、氢氧化钾可视化选择性识别的有机小分子
HU231119B1 (hu) 2018-01-12 2020-11-30 Richter Gedeon Nyrt. Eljárás 4-(4-aminofenil)morfolin-3-on előállítására
CN109651287A (zh) * 2019-01-18 2019-04-19 吕东 一种4-(4-氨基苯基)吗啉酮的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279880A (en) 1965-07-12 1966-10-18 Eastman Kodak Co Polyester textile material dyed with 1-hydroxy-4-n-p-(2'-pyrrolidonyl-1-) phenyl-amino anthraquinones
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
EP0804434A1 (fr) * 1994-08-02 1997-11-05 MERCK SHARP & DOHME LTD. Derives de l'azetidine, de la pyrrolidine et de la piperidine
CA2258093A1 (fr) * 1996-06-28 1998-01-08 Mark E. Duggan Antagonistes du recepteur de fibrinogene
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10105989A1 (de) 2001-02-09 2002-08-14 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
EP1479675A1 (fr) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Derivés d'indazole en tant qu'inhibiteurs du facteur Xa
EP1479676A1 (fr) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Dérivés de benzimidazole en tant qu'inhibiteurs du facteur Xa

Also Published As

Publication number Publication date
EG26605A (en) 2014-03-23
CA2538906C (fr) 2013-04-23
PL1664004T3 (pl) 2015-11-30
KR101148264B1 (ko) 2012-05-21
CN100430384C (zh) 2008-11-05
HK1098134A1 (en) 2007-07-13
BRPI0414382B1 (pt) 2014-01-28
ES2545072T3 (es) 2015-09-08
DE10342570A1 (de) 2005-04-14
US20070066611A1 (en) 2007-03-22
HUE025273T2 (en) 2016-02-29
AU2004272255A1 (en) 2005-03-24
DK1664004T3 (en) 2015-09-07
MXPA06002883A (es) 2006-06-05
JP2007505821A (ja) 2007-03-15
CA2538906A1 (fr) 2005-03-24
AU2004272255B2 (en) 2011-01-06
EP1664004A1 (fr) 2006-06-07
IL174194A (en) 2010-11-30
CN1852902A (zh) 2006-10-25
KR20060070561A (ko) 2006-06-23
SI1664004T1 (sl) 2015-10-30
ZA200602093B (en) 2007-05-30
IL174194A0 (en) 2006-08-01
US7598378B2 (en) 2009-10-06
BRPI0414382A (pt) 2006-11-21
EP1664004B1 (fr) 2015-06-24
WO2005026135A1 (fr) 2005-03-24
PT1664004E (pt) 2015-09-21
CY1116644T1 (el) 2017-03-15
JP4852419B2 (ja) 2012-01-11

Similar Documents

Publication Publication Date Title
IN2012DN00411A (fr)
TW200637837A (en) Fungicides
CY1113578T1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
TW200637853A (en) Fungicides
MXPA05009068A (es) Dihidro-pteridinonas, metodo para la produccion y uso del mismo en la forma de farmacos.
WO2007109080A3 (fr) Inhibiteurs de protéase de l'hépatite c deutérés
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
TW200619205A (en) A method for preparing irbesartan and intermediates thereof
EP1591120A4 (fr) Agonistes de recepteurs
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
PL1758852T3 (pl) Podstawione związki cyklopentenu
MX274842B (es) Procedimiento para la produccion de sales de (4,5-dihidroisoxazol- 3-il)tiocarboxamidina.
TW200621151A (en) Optically active phthalamides
RS51146B (sr) Novi difenil-azetidinon sa poboljšanim fiziološkim osobinama postupak za njegovu proizvodnju,lekovi koji sadrže ovo jedinjenje i njihova upotreba
MXPA05011962A (es) Oxiarenos substituidos.
EA200600485A1 (ru) Способ получения производных 2-оксо-1-пирролидина
TW200510347A (en) Process for organic compounds
UA87710C2 (ru) Способ получения производных [1,4,5]-оксадиазепина
TW200720241A (en) New process for preparing 4,4'-difluorobenzophenone
TW200612959A (en) Method for preparing hydroxamic acids
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
TW200621685A (en) Hydroxynaphthoic acid hydrazide compound and method for preparing the same
MX2009004991A (es) Derivados de monoacetato de ciclopenteno-diol.
MXPA05005761A (es) Proceso para preparar (s)-pantoprazola.
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten